Angela C. Doran

1.5k total citations
25 papers, 642 citations indexed

About

Angela C. Doran is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Angela C. Doran has authored 25 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Angela C. Doran's work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Computational Drug Discovery Methods (5 papers). Angela C. Doran is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Computational Drug Discovery Methods (5 papers). Angela C. Doran collaborates with scholars based in United States and South Korea. Angela C. Doran's co-authors include Bill J. Smith, Cuiping Chen, Frederick Nelson, Stacey L. Becker, John P. Gibbs, Jianhua Liu, Natilie Hosea, Ernesto Callegari, Julie Cianfrogna and Shawn D. Doran and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Pharmaceutical Sciences and Neuropharmacology.

In The Last Decade

Angela C. Doran

25 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela C. Doran United States	14	213	213	178	127	94	25	642
Julie Cianfrogna United States	7	168 0.8×	149 0.7×	108 0.6×	84 0.7×	45 0.5×	7	463
Leanne Cutler United Kingdom	8	156 0.7×	130 0.6×	121 0.7×	63 0.5×	44 0.5×	10	659
Lauren M. Slosky United States	14	460 2.2×	176 0.8×	271 1.5×	67 0.5×	47 0.5×	23	868
Irena Loryan Sweden	15	130 0.6×	221 1.0×	115 0.6×	111 0.9×	103 1.1×	33	624
Christian Namendorf Germany	11	496 2.3×	166 0.8×	113 0.6×	146 1.1×	89 0.9×	16	1.0k
R. Pellicciari Italy	17	341 1.6×	280 1.3×	160 0.9×	24 0.2×	40 0.4×	43	1.1k
Joseph F. Cotten United States	25	579 2.7×	73 0.3×	401 2.3×	41 0.3×	33 0.4×	45	1.3k
Ahmad Tarmizi Che Has Malaysia	9	179 0.8×	59 0.3×	121 0.7×	44 0.3×	30 0.3×	22	492
Tatsuki Koike Japan	14	197 0.9×	37 0.2×	100 0.6×	25 0.2×	45 0.5×	41	642
Harish C. Prasad United States	8	312 1.5×	103 0.5×	288 1.6×	52 0.4×	231 2.5×	8	965

Countries citing papers authored by Angela C. Doran

Since Specialization

Citations

This map shows the geographic impact of Angela C. Doran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela C. Doran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela C. Doran more than expected).

Fields of papers citing papers by Angela C. Doran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela C. Doran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela C. Doran. The network helps show where Angela C. Doran may publish in the future.

Co-authorship network of co-authors of Angela C. Doran

This figure shows the co-authorship network connecting the top 25 collaborators of Angela C. Doran. A scholar is included among the top collaborators of Angela C. Doran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela C. Doran. Angela C. Doran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bauman, Jonathan, Angela C. Doran, Brian Hee, et al.. (2024). The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans. Drug Metabolism and Disposition. 52(10). 1124–1136. 7 indexed citations

Dowty, Martin E., Ruolun Qiu, Alyssa Dantonio, et al.. (2024). The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite. Drug Metabolism and Disposition. 52(7). 690–702. 4 indexed citations

Callegari, Ernesto, Susanna Tse, Angela C. Doran, Theunis C. Goosen, & M. Naveed Shaik. (2023). Physiologically Based Pharmacokinetic Modeling of the Drug–Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study. The Journal of Clinical Pharmacology. 64(1). 80–93. 2 indexed citations

Doran, Angela C., et al.. (2022). An Improved Method for Cytochrome P450 Reaction Phenotyping Using a Sequential Qualitative-Then-Quantitative Approach. Drug Metabolism and Disposition. 50(9). 1272–1286. 7 indexed citations

Bauman, Jonathan, Angela C. Doran, Amanda King‐Ahmad, et al.. (2022). The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in Humans. Drug Metabolism and Disposition. 50(8). 1106–1118. 24 indexed citations

Doran, Angela C., Woodrow Burchett, Heather Eng, et al.. (2022). Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting Approach. Drug Metabolism and Disposition. 50(9). 1259–1271. 15 indexed citations

Dantonio, Alyssa, Angela C. Doran, & R. Scott Obach. (2021). Intersystem Extrapolation Factors Are Substrate-Dependent for CYP3A4: Impact on Cytochrome P450 Reaction Phenotyping. Drug Metabolism and Disposition. 50(3). 249–257. 9 indexed citations

Kim, Dae Wook, Cheng Chang, Xian Chen, et al.. (2019). Systems approach reveals photosensitivity and PER 2 level as determinants of clock‐modulator efficacy. Molecular Systems Biology. 15(7). e8838–e8838. 31 indexed citations

Feng, Bo, Angela C. Doran, Li Di, et al.. (2018). Prediction of Human Brain Penetration of P-glycoprotein and Breast Cancer Resistance Protein Substrates Using In Vitro Transporter Studies and Animal Models. Journal of Pharmaceutical Sciences. 107(8). 2225–2235. 27 indexed citations

10.

Sawant‐Basak, Aarti, R. Scott Obach, Angela C. Doran, et al.. (2018). Metabolism of a 5HT6 Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug Interaction. Drug Metabolism and Disposition. 46(7). 934–942. 6 indexed citations

11.

Modi, Meera E., Mark J. Majchrzak, Kari R. Fonseca, et al.. (2016). Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing. Journal of Pharmacology and Experimental Therapeutics. 358(2). 164–172. 24 indexed citations

12.

Shaffer, Christopher L., Sarah M. Osgood, Jessica Mancuso, & Angela C. Doran. (2014). Diphenhydramine has Similar Interspecies Net Active Influx at the Blood–Brain Barrier. Journal of Pharmaceutical Sciences. 103(5). 1557–1562. 12 indexed citations

13.

Kim, Jae Kyoung, Daniel B. Forger, M. Marconi, et al.. (2013). Modeling and Validating Chronic Pharmacological Manipulation of Circadian Rhythms. CPT Pharmacometrics & Systems Pharmacology. 2(7). 1–11. 41 indexed citations

14.

Mente, Scot, Angela C. Doran, & Travis T. Wager. (2012). Getting the MAX out of Computational Models: The Prediction of Unbound-Brain and Unbound-Plasma Maximum Concentrations. ACS Medicinal Chemistry Letters. 3(6). 515–519. 1 indexed citations

15.

Doran, Angela C., Sarah M. Osgood, Jessica Mancuso, & Christopher L. Shaffer. (2012). An Evaluation of Using Rat-Derived Single-Dose Neuropharmacokinetic Parameters to Project Accurately Large Animal Unbound Brain Drug Concentrations. Drug Metabolism and Disposition. 40(11). 2162–2173. 29 indexed citations

16.

Siok, Chester J., et al.. (2011). Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: Effects on hippocampal and cortical EEG patterns in rats. Neuropharmacology. 62(1). 226–236. 18 indexed citations

17.

Duplantier, Allen J., Ivan Efremov, Angela C. Doran, et al.. (2009). 3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization. Bioorganic & Medicinal Chemistry Letters. 19(9). 2524–2529. 21 indexed citations

18.

Zhang, Lei, Bruce N. Rogers, Allen J. Duplantier, et al.. (2008). 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: A novel series of mGluR2 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 18(20). 5493–5496. 13 indexed citations

19.

Liu, Xingrong, Bill J. Smith, Cuiping Chen, et al.. (2006). Evaluation of Cerebrospinal Fluid Concentration and Plasma Free Concentration As a Surrogate Measurement for Brain Free Concentration. Drug Metabolism and Disposition. 34(9). 1443–1447. 129 indexed citations

20.

Liu, Xingrong, Bill J. Smith, Cuiping Chen, et al.. (2005). Use of a Physiologically Based Pharmacokinetic Model to Study the Time to Reach Brain Equilibrium: An Experimental Analysis of the Role of Blood-Brain Barrier Permeability, Plasma Protein Binding, and Brain Tissue Binding. Journal of Pharmacology and Experimental Therapeutics. 313(3). 1254–1262. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact